Unique POC CRP Analyser Reduces Unnecessary Hospital Admissions

Horiba UK Ltd, Medical announces that Thame and Marlow Community Hubs, within Buckinghamshire Healthcare NHS Trust, have each recently installed Horiba Medical’s latest point-of-care testing analyser, the Microsemi CRP. These new analysers are now streamlining existing diagnostic pathways in the community and helping to reduce local A&E admissions for frail patients.

The Microsemi CRP is a compact and user-friendly ‘near-patient’ analyser which uniquely delivers a lab-accurate, 3-part differential full blood count (FBC) combined with a C-reactive protein (CRP) measurement from a single tiny 18μL whole blood sample within just 4 minutes. Information gathered from the analyser is of great value in determining the presence of bacterial infection and inflammation, and given the rapidity of results delivered, patients can receive the treatment they need straight away, or be referred appropriately and without delay.

Opened in 2017, the new Frailty Assessment Hubs located at both Thame and Marlow Community Hospitals (alongside those already existing at Stoke Mandeville & Wycombe Hospitals), offer a ‘one-stop shop’ for frail patients in the locality to receive the care they need closer to home. These also have the added benefit of reducing pressure on the local acute sites by reducing unnecessary admissions - particularly during the busier winter months. Teams of elderly care consultants, nurses, therapists, paramedics and GPs are available on site to provide expert assessments, undertake tests and agree a treatment plan with patients. If required, they can refer patients to the right community or hospital team to provide ongoing support or treatment.

Commenting on the beneficial impact of the Microsemi CRP analyser, Shelagh Wojtowicz, Staff Nurse at Marlow Community Hub, said: “Patients see it as an advantage. Before the analyser was installed, we sent our samples away via two collection slots. Of course, this meant that patients were not able to access their results until 1-2 days later, whereas now, we can perform a combined FBC and CRP, see a result within 4 minutes and take the relevant course of action almost immediately. It also means that patient samples don’t get lost.”